We, therefore, speculate that carcinogenesis disturbs the cell–cell and cell–matrix interactions in which FES is involved in normal urinary bladder urothelium, leading to reduced FES expression in cancer cells, especially those of high-grade tumors. The gene discussed is FES; the disease is cancer.